Skip to main content
Equibles
IRD logo

IRD · Opus Genetics, Inc. · Analyst Estimates

Track IRD — free

Use IRD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IRD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.27 +0.34 (+8.65%) At close · Nov 4
Russell 2000 member Rebalance outlook locked
Market Cap
$326.96M
Shares
83.20M
Volume · Nov 4 1.16M Avg daily vol (3M) 2.48M

Analyst Estimates

Compare analyst forecasts for Opus Genetics, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-21 22:25 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.24
-0.94
-0.28
12
-0.94
-0.94
-0.92
-1.00
0
0
1
1
Revenue
USD
Publication date not stated
2.90M
13.75M
28.78M
18
 — — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.24
-0.72
-0.40
12
-0.72
-0.72
-0.71
-0.76
0
0
0
2
Revenue
USD
Publication date not stated
0.00
13.62M
32.36M
17
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.21
-0.15
-0.09
12
-0.15
-0.15
-0.15
-0.16
0
0
1
1
Revenue
USD
Publication date not stated
0.00
2.08M
7.00M
18
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.19
-0.036
0.39
12
-0.037
-0.037
-0.048
-0.048
0
0
1
1
Revenue
USD
Publication date not stated
0.00
8.19M
22.60M
18
 — — — — — — — —
Key facts CIK 1228627 CUSIP 67577R102 13F (30d) 23 filings 23 filers Visit website Investor relations